Search results for: 'Cancer Diagnostics Market'

The IVD market constantly changing. Mega Trends such as consolidation, automation, and reimbursement policies affect every aspect of the market. This study looks at the effects of these trends on three global consumer segments: hospitals, laboratories, and patients. The growing importance of diagnostics in patient care is expanding beyond hospitals...

This study addresses the current shift from in-hospital settings to non-hospital or outpatient settings for medical imaging service providers in the US and EU. The focus is on X-ray, ultrasound, mammography, MRI, and imaging IT solutions delivered in outpatient settings, such as ambulatory surgery centers (ASCs), independent imaging diagnostic cent...

15 Apr 2021  |  Global  |  Technology Research

Advanced Micro- and Nanofluidics Revolutionizing the Point of Care Diagnostic Industry

Disruptive microfluidic technologies enabling decentralization of diagnostic tests

Infographics

×

Microfluidics which manipulate small volumes of fluid in microchannels enable gentle manipulation of cells and molecules and precise control of experimental conditions. It allows miniaturization of bulk assays in small devices requiring small volumes of samples and reagents and integration of several components for multiplexing analysis and achievi...

01 Jul 2015  |  North America  |  Market Research

Analysis of the US and European Diabetes Diagnostics Market

Constricting Reimbursement Policies Restrain Market Growth

Infographics

×

The diabetes diagnostics markets in the United States and Europe have been in a mature stage for many years. Growth is sustained due to the high prevalence of diabetes in both regions. The segments covered in the study are self-monitoring of blood glucose (SMBG), point-of-care testing (POCT), and lab-based HbA1c testing. The emerging market of non-...

27 Aug 2020  |  Global  |  Market Research

Smart Labs as Key Drivers for the Digital Transformation of Diagnostic Laboratories, 2020

Robotic Automation, Internet of Things (IoT), and Artificial Intelligence (AI) Offering Growth Opportunities for Academic and Commercial Diagnostics Labs

Infographics

×

Key Issues Addressed

Diagnostic academic and commercial research labs suffer from cost pressures, given the ongoing Protecting Access to Medicare Act (PAMA) regulations and reproducibility issues, and are under productivity strain. The recent COVID-19 pandemic leading to increasing test volumes and renewed focus on research and development (R&D) to drive innovation wil...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) highlights recent advances in biological therapies such as RNA therapies, biosimilars, gene therapies and cell therapies for the management of diseases such as cancer, neurodegenerative disorders and rare diseases. The research also provides technological insigh...

The aim of this research service is to analyse the diabetes diagnostics market in Europe and provide strategic recommendations and conclusions for the success of its participants. The main objective of this research service is to establish an understanding of the key diabetes diagnostics market segments (laboratory-based HbA1C diagnostics, SMBG and...

03 Feb 2021  |  North America  |  Market Research

Companion Diagnostics (CDx) is Revolutionizing the Global Clinical Next-generation Sequencing (NGS) Market

Next-generation Blockchain-Powered Genomic Data Marketplaces are Creating New Growth Opportunities

Infographics

×

2020 will be remembered for the COVID-19 pandemic, masks, social distancing protocol, alternate care sites, Moderna, Pfizer, BioNTech, AstraZeneca, RT-PCR, and serology testing (or all the above). However, in the midst of our response to the global pandemic, remarkable advancements were made in another great frontier in medicine that remains unconq...

This research service explores the market for therapeutics used for the treatment of breast cancer in the Unites States of America. It analyzes the various challenges faced by pharmaceutical companies, and the competitive advantages and disadvantages of their products in the market.